| HOME >> BIOLOGY >> TECHNOLOGY |
(unaudited)
(in thousands, except per share data)
Three Months Nine Months
Ended Ended
September 30, September 30,
2007 2006 2007 2006
Revenues $16,171 $6,911 $40,770 $16,190
Cost of revenues 6,513 3,768 16,543 9,308
Gross profit 9,658 3,143 24,227 6,882
Operating expenses:
Sales and marketing expenses 3,127 1,624 7,869 4,137
General and administrative expenses 2,732 1,985 6,997 4,968
Research and development expenses 143 271 463 860
Impairment and lease exit costs - - - 542
Total operating expenses 6,002 3,880 15,329 10,507
Income (loss) from operations 3,656 (737) 8,898 (3,625)
Other income (expense):
Interest income 118 55 245 193
Interest expense (72) (96) (231) (288)
Other income (1) 7 41 319
Income (loss) before income taxes 3,701 (771) 8,953 (3,401)
Provision for income taxes (114) - (274) -
Net income (loss) $3,587 $(771) $8,679 $(3,401)
Net income (loss) per share (1):
Basic $0.43 $(6.07) $0.82 $(34.50)
Diluted $0.06 $(6.07) $0.10 $(34.50)
Shares used to compute net income
(loss) per share (1):
Basic
'/>"/>
| SOURCE Genoptix, Inc. Copyright©2007 PR Newswire. All rights reserved |